Tidal Vision
Assembly Line
Tidal Vision completes $140M Series B to Scale Chitosan Technologies Globally
Tidal Vision, a biotechnology company, has completed a $140M Series B financing round, exceeding its original target due to high demand from strategically aligned investors. The funding will fuel the company’s global expansion, with new facilities being built in Europe, Texas, and Ohio, to increase production capacities and research and development resources for chitosan-based solutions. This expansion will enable Tidal Vision to better serve customers in critical industries, such as water treatment, agriculture, and material science, and make chitosan-based solutions more accessible globally. The company aims to create positive and systemic environmental impact by making its biomolecular solutions more economical, better performing, and easier to adopt. With this investment, Tidal Vision will accelerate its research and development in chitosan and adjacent technologies, adding to its already impressive intellectual property portfolio.